![](/img/cover-not-exists.png)
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, Luisa, Pugliese, Daniela, Tonucci, Tommaso Panici, Bertani, Lorenzo, Costa, Francesco, Privitera, Giuseppe, Tolusso, Barbara, Di Mario, Clara, Albano, Eleonora, Tapete, Gherardo, Gremese, ElisaVolume:
7
Language:
english
Journal:
United European Gastroenterology Journal
DOI:
10.1177/2050640619873784
Date:
November, 2019
File:
PDF, 381 KB
english, 2019